The Na/K-ATPase: A potential therapeutic target in cardiometabolic diseases.

Milan Obradovic, Emina Sudar-Milovanovic, Zoran Gluvic, Katarina Banjac, Manfredi Rizzo, Esma R Isenovic

Journal: Frontiers in endocrinology 2023;14():1150171

PMID: 36926029

Free Full Text on PubMed Central View on PubMed

Abstract

Cardiometabolic diseases (CMD) are a direct consequence of modern living and contribute to the development of multisystem diseases such as cardiovascular diseases and diabetes mellitus (DM). CMD has reached epidemic proportions worldwide. A sodium pump (Na/K-ATPase) is found in most eukaryotic cells' membrane and controls many essential cellular functions directly or indirectly. This ion transporter and its isoforms are important in the pathogenesis of some pathological processes, including CMD. The structure and function of Na/K-ATPase, its expression and distribution in tissues, and its interactions with known ligands such as cardiotonic steroids and other suspected endogenous regulators are discussed in this review. In addition, we reviewed recent literature data related to the involvement of Na/K-ATPase activity dysfunction in CMD, focusing on the Na/K-ATPase as a potential therapeutic target in CMD.

Address: Department of Radiobiology and Molecular Genetics, "VINČA" Institute of Nuclear Sciences - National Institute of thе Republic of Serbia, University of Belgrade, Belgrade, Serbia.; University Clinical-Hospital Centre Zemun-Belgrade, Clinic of Internal medicine, School of Medicine, University of Belgrade, Belgrade, Serbia.; School of Medicine, Promise Department, University of Palermo, Palermo, Italy.

DOI: 10.3389/fendo.2023.1150171

Link outs

Free resources

Full Text Sources:

MeSH Terms: Humans, Cardiac Glycosides, Sodium-Potassium-Exchanging ATPase, Cell Membrane, Cardiovascular Diseases